Antiproliferative factor regulates connective tissue growth factor (CTGF/CCN2) expression in T24 bladder carcinoma cells

Molecular Biology of the Cell

Volumn 23, Issue 10, 2012, Pages 1976-1985

  Matika, Christina A ^a   Wasilewski, Melissa ^a   Arnott, John A ^a   Planey, Sonia Lobo ^a  

^a Geisinger Health Geisinger Commonwealth School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROLIFERATIVE FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; CYTOSKELETON ASSOCIATED PROTEIN 4; GLYCOPEPTIDE; LUCIFERASE; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLADDER CARCINOMA; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; CELL NUCLEUS; CONNECTIVE TISSUE GROWTH FACTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861176253     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-08-0714     Document Type: Article

References (54)

1. Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002). Connectivetissue growth factor (CTGF) modulates cell signalling by BMP and TGFbeta. Nat Cell Biol 4, 599-604.
2. Bates SR (2010). P63 (CKAP4) as an SP-A receptor: implications for surfactant turnover. Cell Physiol Biochem 25, 41-54.
3. Brigstock DR (2003). The CCN family: a new stimulus package. J Endocrinol 178, 169-175.
4. Brigstock DR et al. (2003). Proposal for a unified CCN nomenclature. Mol Pathol 56, 127-128. (Pubitemid 36461474)
5. Chang CC, Shih JY, Jeng YM, Su JL, Lin BZ, Chen ST, Chau YP, Yang PC, Kuo ML (2004). Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 96, 364-375.
6. Chaqour B, Whitbeck C, Han JS, Macarak E, Horan P, Chichester P, Levin R (2002). Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction. Am J Physiol Endocrinol Metab 283, E765-E774.
7. Chen CC, Lau LF (2009). Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41, 771-783.
8. Chien W, Yin D, Gui D, Mori A, Frank JM, Said J, Kusuanco D, Marchevsky A, McKenna R, Koeffler HP (2006). Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells. Mol Cancer Res 4, 591-598. (Pubitemid 44341368)
9. Chuang JY, Yang WY, Lai CH, Lin CD, Tsai MH, Tang CH (2011). CTGF inhibits cell motility and COX-2 expression in oral cancer cells. Int Immunopharmacol 11, 948-954.
10. Conrads TP, Tocci GM, Hood BL, Zhang CO, Guo L, Koch KR, Michejda CJ, Veenstra TD, Keay SK (2006). CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J Biol Chem 281, 37836-37843. (Pubitemid 46042086)
11. Deng WG, Zhu Y, Montero A, Wu KK (2003). Quantitative analysis of binding of transcription factor complex to biotinylated DNA probe by a streptavidin-agarose pulldown assay. Anal Biochem 323, 12-18. (Pubitemid 37393352)
12. Deng YZ, Chen PP, Wang Y, Yin D, Koeffler HP, Li B, Tong XJ, Xie D (2007). Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through betacatenin- T-cell factor/Lef signaling. J Biol Chem 282, 36571-36581.
13. Erickson DR (1999). Interstitial cystitis: update on etiologies and therapeutic options. J Womens Health Gend Based Med 8, 745-758.
14. Goldschmeding R, Aten J, Ito Y, Blom I, Rabelink T, Weening JJ (2000). Connective tissue growth factor: just another factor in renal fibrosis. Nephrol Dial Transplant 15, 296-299. (Pubitemid 30116458)
15. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K (1996). Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106, 729-733. (Pubitemid 26119731)
16. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE (2004). Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11, 781-791. (Pubitemid 40065551)
17. Kazi AS, Tao JQ, Feinstein SI, Zhang L, Fisher AB, Bates SR (2010). Role of the PI3-kinase signaling pathway in trafficking of the surfactant protein A receptor P63 (CKAP4) on type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 299, L794-L807.
18. Keay S (2008). Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal 20, 2174-2179.
19. Keay S, Kleinberg M, Zhang CO, Hise MK, Warren JW (2000). Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol 164, 2112-2118.
20. Keay S, Seillier-Moiseiwitsch F, Zhang CO, Chai TC, Zhang J (2003a). Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 14, 107-115. (Pubitemid 37345219)
21. Keay S, Zhang CO, Chai T, Warren J, Koch K, Grkovic D, Colville H, Alexander R (2004a). Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 63, 22-26. (Pubitemid 38147541)
22. Keay S, Zhang CO, Shoenfelt JL, Chai TC (2003b). Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology 61, 1278-1284. (Pubitemid 36694033)
23. Keay S, Zhang CO, Trifillis AL, Hise MK, Hebel JR, Jacobs SC, Warren JW (1996). Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156, 2073-2078. (Pubitemid 26378056)
24. Keay SK, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ Jr, Zhang CO, Koch KR, Michejda CJ (2004b). An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA 101, 11803-11808. (Pubitemid 39095375)
25. Keay SK, Zhang CO, Shoenfelt J, Erickson DR, Whitmore K, Warren JW, Marvel R, Chai T (2001). Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 57, 9-14. (Pubitemid 33733960)
26. Kim J, Keay SK, Dimitrakov JD, Freeman MR (2007). p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells. FEBS Lett 581, 3795-3799. (Pubitemid 47102303)
27. Klopfenstein DR, Kappeler F, Hauri HP (1998). A novel direct interaction of endoplasmic reticulum with microtubules. EMBO J 17, 6168-6177. (Pubitemid 28497790)
28. Klopfenstein DR, Klumperman J, Lustig A, Kammerer RA, Oorschot V, Hauri HP (2001). Subdomain-specific localization of CLIMP-63 (p63) in the endoplasmic reticulum is mediated by its luminal alpha-helical segment. J Cell Biol 153, 1287-1300.
29. Lau LF, Lam SC (1999). The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248, 44-57. (Pubitemid 29393928)
30. Leask A, Abraham DJ (2006). All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119, 4803-4810. (Pubitemid 46017793)
31. Lin BR et al. (2005). Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology 128, 9-23.
32. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC (2004). Connectivetissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131, 2137-2147. (Pubitemid 38702045)
33. Moussad EE, Brigstock DR (2000). Connective tissue growth factor: what's in a name. Mol Genet Metab 71, 276-292.
34. Oemar BS, Luscher TF (1997). Connective tissue growth factor. Friend or foe. Arterioscler Thromb Vasc Biol 17, 1483-1489. (Pubitemid 27387766)
35. Perbal B (2001). The CCN family of genes: a brief history. Mol Pathol 54, 103-104.
36. Perbal B (2004). CCN proteins: multifunctional signalling regulators. Lancet 363, 62-64.
37. Planey SL, Keay SK, Zhang CO, Zacharias DA (2009). Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling. Mol Biol Cell 20, 1454-1463.
38. Planey SL, Zacharias DA (2009). Palmitoyl acyltransferases, their substrates, and novel assays to connect them (review). Mol Membr Biol 26, 14-31.
39. Rashid HH, Reeder JE, O Connell MJ, Zhang CO, Messing EM, Keay SK (2004). Interstitial cystitis antiproliferative factor (APF) as a cell-cycle modulator. BMC Urol 4, 3.
40. Razzaq TM, Bass R, Vines DJ, Werner F, Whawell SA, Ellis V (2003). Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4). J Biol Chem 278, 42679-42685. (Pubitemid 37310542)
41. Schweizer A, Ericsson M, Bachi T, Griffiths G, Hauri HP (1993). Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway. J Cell Sci 104, Pt 3671-683.
42. Schweizer A, Rohrer J, Hauri HP, Kornfeld S (1994). Retention of p63 in an ER-Golgi intermediate compartment depends on the presence of all three of its domains and on its ability to form oligomers. J Cell Biol 126, 25-39. (Pubitemid 24214926)
43. Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG, Schuppan D (2001). Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 158, 1239-1244. (Pubitemid 32281287)
44. Shahjee HM, Koch KR, Guo L, Zhang CO, Keay SK (2010). Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res 29, 160.
45. Vedrenne C, Hauri HP (2006). Morphogenesis of the endoplasmic reticulum: beyond active membrane expansion. Traffic 7, 639-646. (Pubitemid 43676973)
46. Vedrenne C, Klopfenstein DR, Hauri HP (2005). Phosphorylation controls CLIMP-63-mediated anchoring of the endoplasmic reticulum to microtubules. Mol Biol Cell 16, 1928-1937. (Pubitemid 40471960)
47. Vinson C, Acharya A, Taparowsky EJ (2006). Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta 1759, 4-12.
48. Wang SC (2009). Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors. Clin Cancer Res 15, 6484-6489.
49. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61, 8917-8923. (Pubitemid 34013909)
50. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP (2004). Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10, 2072-2081. (Pubitemid 38375569)
51. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR (2005). Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65, 8887-8895. (Pubitemid 41377378)
52. Yang W et al. (2011). Quantitative proteomics identifies a beta-catenin network as an element of the signaling response to Frizzled-8 proteinrelated antiproliferative factor. Mol Cell Proteomics 10, M110 007492.
53. Zhang CO, Wang JY, Koch KR, Keay S (2005). Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J Urol 174, 2382-2387. (Pubitemid 41611833)
54. Zhang J, Planey SL, Ceballos C, Stevens SM Jr, Keay SK, Zacharias DA (2008). Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method. Mol Cell Proteomics 7, 1378-1388. (Pubitemid 352038279)